Q3 2018 Holdings
Filed 2018-11-13 | 212 holdings | $297.1M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↑ | Shares | % Portfolio |
|---|---|---|---|---|---|
| CymaBay Therapeutics, Inc.(CBAYUSD) | Common | 23257D103 | $1.9K | 169,962 | 0.0% |
| Spectrum Pharmaceuticals, Inc. | Common | 84763A108 | $1.9K | 114,670 | 0.0% |
| Revance Therapeutics, Inc.(RVNCEUR) | Common | 761330109 | $1.9K | 77,919 | 0.0% |
| Intellia Therapeutics, Inc.(NTLA) | Common | 45826J105 | $2.0K | 68,671 | 0.0% |
| Healthcare Realty Trust Incorporated | Common | 421946104 | $2.0K | 68,000 | 0.0% |
| Immunomedics, Inc.(IMMU) | Common | 452907108 | $2.0K | 97,370 | 0.0% |
| Waters Corporation(WAT) | Common | 941848103 | $2.1K | 10,800 | 0.0% |
| Laboratory Corporation of America Holdings | Sponsored ADR | 50540R409 | $2.1K | 12,200 | 0.0% |
| Mettler-Toledo International Inc.(MTD) | Common | 592688105 | $2.1K | 3,500 | 0.0% |
| Repligen Corporation(RGEN) | Common | 759916109 | $2.1K | 38,700 | 0.0% |
| Dentsply Sirona Inc.(XRAY) | Common | 24906P109 | $2.2K | 57,600 | 0.0% |
| Iqvia Holdings Inc.(IQV) | Common | 46266C105 | $2.2K | 16,800 | 0.0% |
| Clovis Oncology, Inc.(CLVSEUR) | Common | 189464100 | $2.2K | 75,400 | 0.0% |
| Protagonist Therapeutics, Inc.(PTGX) | Common | 74366E102 | $2.3K | 219,042 | 0.0% |
| PTC Therapeutics, Inc.(PTCT) | Common | 69366J200 | $2.3K | 48,390 | 0.0% |
| Aerpio Pharmaceuticals, Inc. | Common | 00810B105 | $2.4K | 765,000 | 0.0% |
| Tetraphase Pharmaceuticals, Inc. | Common | 88165N105 | $2.4K | 859,322 | 0.0% |
| Aerie Pharmaceuticals, Inc.(AERIEUR) | Common | 00771V108 | $2.4K | 38,770 | 0.0% |
| Evolent Health, Inc.(EVH) | Common | 30050B101 | $2.4K | 84,300 | 0.0% |
| Genomic Health, Inc.(GHDX) | Common | 37244C101 | $2.4K | 34,740 | 0.0% |
| Iovance Biotherapeutics, Inc.(IOVA) | Common | 462260100 | $2.4K | 216,908 | 0.0% |
| Editas Medicine, Inc.(EDIT) | Common | 28106W103 | $2.4K | 76,668 | 0.0% |
| Ligand Pharmaceuticals Incorporated(LGND) | Common | 53220K504 | $2.5K | 8,940 | 0.0% |
| Innoviva, Inc.(INVA) | Common | 45781M101 | $2.5K | 161,603 | 0.0% |
| MyoKardia, Inc. | Common | 62857M105 | $2.5K | 38,600 | 0.0% |
| Dermira, Inc.(DERMEUR) | Common | 24983L104 | $2.6K | 234,200 | 0.0% |
| Perrigo Company plc(PRGO) | Shares | G97822103 | $2.6K | 37,300 | 0.0% |
| Henry Schein, Inc.(HSIC) | Common | 806407102 | $2.7K | 31,400 | 0.0% |
| Trillium Therapeutics Inc. | Common | 89620X506 | $2.7K | 468,399 | 0.0% |
| Sangamo Therapeutics, Inc.(SGMO) | Common | 800677106 | $2.9K | 171,889 | 0.0% |
| Welltower Inc.(WELL) | Common | 95040Q104 | $2.9K | 45,560 | 0.0% |
| Varian Medical Systems, Inc.(VAREUR) | Common | 92220P105 | $2.9K | 26,227 | 0.0% |
| Ovid Therapeutics Inc.(OVID) | Common | 690469101 | $3.0K | 535,824 | 0.0% |
| Nightstar Therapeutics plc | ADR | 65413A101 | $3.1K | 150,000 | 0.0% |
| Portola Pharmaceuticals, Inc. | Sponsored ADR | 737010108 | $3.1K | 115,448 | 0.0% |
| New Senior Investment Group Inc. | Common | 648691103 | $3.1K | 528,919 | 0.0% |
| Horizon Pharma plc | Shares | G4617B105 | $3.2K | 162,900 | 0.0% |
| Zogenix, Inc. | Common | 98978L204 | $3.3K | 66,182 | 0.0% |
| Marinus Pharmaceuticals, Inc. | Common | 56854Q101 | $3.4K | 336,228 | 0.0% |
| Verona Pharma plc(VRNA) | Sponsored ADR | 925050106 | $3.4K | 275,000 | 0.0% |
| Avadel Pharmaceuticals plc | Sponsored ADR | 05337M104 | $3.6K | 814,588 | 0.0% |
| PRA Health Sciences, Inc.(PRAH) | Common | 69354M108 | $3.6K | 32,460 | 0.0% |
| Tesaro, Inc. | Common | 881569107 | $3.7K | 94,970 | 0.0% |
| Sutro Biopharma, Inc. | Common | 869367102 | $3.8K | 250,000 | 0.0% |
| Puma Biotechnology, Inc.(PBYI) | Common | 74587V107 | $3.8K | 83,340 | 0.0% |
| Nevro Corp.(NVROEUR) | Common | 64157F103 | $3.9K | 68,760 | 0.0% |
| Agilent Technologies, Inc.(A) | Common | 00846U101 | $4.0K | 56,800 | 0.0% |
| Steris plc(STE) | Shares | G84720104 | $4.0K | 35,203 | 0.0% |
| Albireo Pharma, Inc.(BDQM) | Common | 01345P106 | $4.1K | 125,000 | 0.0% |
| Foamix Pharmaceuticals Ltd. | Shares | M46135105 | $4.2K | 727,205 | 0.0% |